The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of armored huCART19-IL18 in patients with relapsed/refractory lymphomas that progressed after anti-CD19 CAR T cells.
 
Jakub Svoboda
Consulting or Advisory Role - Adaptive Biotechnologies; AstraZeneca; Atara Biotherapeutics; BMS; Crispr therapeutics; Pharmacyclics; Seagen
Research Funding - Adaptive Biotechnologies (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
 
Daniel J Landsburg
Consulting or Advisory Role - ADC Therapeutics; Epizyme; Incyte; Karyopharm Therapeutics; MorphoSys
Speakers' Bureau - Seagen
Research Funding - Calithera Biosciences; Curis (Inst)
Other Relationship - Karyopharm Therapeutics
 
Sunita Dwivedy Nasta
Research Funding - Gilead Sciences (Inst); Pharmacyclics (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst)
 
Stefan K. Barta
Honoraria - Acrotech Biopharma; Affimed Therapeutics; Daiichi Sankyo/Lilly; Janssen Oncology; Kyowa Kirin International
Consulting or Advisory Role - Acrotech Biopharma
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Genmab; Kyowa Kirin International; Seagen
 
Elise A. Chong
Consulting or Advisory Role - BeiGene; Novartis; TG Therapeutics
Research Funding - Genentech/Roche
 
Michael J. Lariviere
Research Funding - Merck (Inst)
 
Joanne Shea
No Relationships to Disclose
 
Amanda Cervini
No Relationships to Disclose
 
Elizabeth O. Hexner
Consulting or Advisory Role - Blueprint Medicines; PharmaEssentia
Research Funding - Blueprint Medicines (Inst); Novartis (Inst); Samus Therapeutics (Inst); Tmunity Therapeutics, Inc. (Inst)
 
Amy Marshall
No Relationships to Disclose
 
Megan Four
No Relationships to Disclose
 
Rachel M. Leskowitz
No Relationships to Disclose
 
Megan M. Davis
Consulting or Advisory Role - BlueWhaleBio; Cellares; Tmunity Therapeutics, Inc.
Research Funding - Danaher (Inst)
Patents, Royalties, Other Intellectual Property - BlueWhaleBio; Novartis Institutes for BioMedical Research; Tmunity Therapeutics, Inc.
 
Wei-Ting Hwang
Employment - Janssen (I)
Research Funding - Novartis
 
Noelle V. Frey
Consulting or Advisory Role - Kite, a Gilead Company; Mneumo Therapeutics; Pfizer; Sana Biotechnology
Research Funding - Novartis (Inst)
 
Donald L. Siegel
No Relationships to Disclose
 
Joseph A. Fraietta
No Relationships to Disclose
 
David L. Porter
Employment - Genentech/Roche (I)
Stock and Other Ownership Interests - Roche; Tmunity Therapeutics, Inc.
Honoraria - Adecept Bio; Elsevier
Consulting or Advisory Role - Angiocrine Bioscience; Bluebird Bio; BMS GmbH & Co. KG; DeCART Therapeutics; Genentech; Gerson Lerham; Gilead Sciences; Incyte; Janssen; Jazz Pharmaceuticals; Kadmon; Mirror; Novartis
Research Funding - Novartis (Inst)
 
Stephen J. Schuster
Consulting or Advisory Role - Acerta Pharma/AstraZeneca; BeiGene; Celgene; Genentech/Roche; Incyte; Janssen; Legend Biotech; Loxo; MorphoSys; MustangBio; Novartis; Regeneron
Research Funding - Abbvie (Inst); Adaptive Biotechnologies (Inst); Celgene (Inst); DTRM (Inst); Genentech/Roche (Inst); Incyte (Inst); Juno Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent Combination Therapies of CAR and PD-1 Inhibitors (via University of Pennsylvania with royalties to Novartis)
 
Carl H. June
Employment - Capstan Therapeutics; Poseida Therapeutics; Tmunity Therapeutics, Inc.
Consulting or Advisory Role - AC Immune; Alaunos; Bluesphere Bio; Cabaletta Bio; Carisma Therapeutics; Cellares; Verismo
Research Funding - Capstan Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Novartis; Tmunity Therapeutics, Inc. (Inst)